Cargando…
An integrated strategy for deciding open versus laparoscopic hepatectomy for resectable primary liver cancer
BACKGROUND: Laparoscopic liver resection (LLR) is now widely performed in treating primary liver cancer (PLC) and yields equal long-term and superior short-term outcomes to those of open liver resection (OLR). The optimal surgical approach for resectable PLC (rPLC) remains controversial. Herein, we...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972775/ https://www.ncbi.nlm.nih.gov/pubmed/36849920 http://dx.doi.org/10.1186/s12885-023-10630-x |
_version_ | 1784898388524793856 |
---|---|
author | Fu, Yizhen Yang, Zhenyun Hu, Zili Yang, Zhoutian Chen, Jinbin Wang, Juncheng Zhou, Zhongguo Xu, Li Chen, Minshan Zhang, Yaojun |
author_facet | Fu, Yizhen Yang, Zhenyun Hu, Zili Yang, Zhoutian Chen, Jinbin Wang, Juncheng Zhou, Zhongguo Xu, Li Chen, Minshan Zhang, Yaojun |
author_sort | Fu, Yizhen |
collection | PubMed |
description | BACKGROUND: Laparoscopic liver resection (LLR) is now widely performed in treating primary liver cancer (PLC) and yields equal long-term and superior short-term outcomes to those of open liver resection (OLR). The optimal surgical approach for resectable PLC (rPLC) remains controversial. Herein, we aimed to develop a nomogram to determine the most appropriate resection approach for the individual patient. METHODS: Patients with rPLC who underwent hepatectomy from January 2013 to December 2018 were reviewed. Prediction model for risky surgery during LLR was constructed. RESULTS: A total of 900 patients in the LLR cohort and 423 patients in the OLR cohort were included. A history of previous antitumor treatment, tumor diameter, tumor location and resection extent were independently associated with risky surgery of LLR. The nomogram which was constructed based on these risk factors demonstrated good accuracy in predicting risky surgery with a C index of 0.83 in the development cohort and of 0.76 in the validation cohort. Patients were stratified into high-, medium- or low-risk levels for receiving LLR if the calculated score was more than 0.8, between 0.2 and 0.8 or less than 0.2, respectively. High-risk patients who underwent LLR had more blood loss (441 ml to 417 ml) and a longer surgery time (183 min to 150 min) than those who received OLR. CONCLUSIONS: Patients classified into the high-risk level for LLR instead undergo OLR to reduce surgical risks and complications and patients classified into the low-risk level undergo LLR to maximize the advantages of minimally invasive surgery. TRIAL REGISTRATION: This study was registered in the Chinese Clinical Trial Registry (registration number: ChiCTR2100049446). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-023-10630-x. |
format | Online Article Text |
id | pubmed-9972775 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-99727752023-03-01 An integrated strategy for deciding open versus laparoscopic hepatectomy for resectable primary liver cancer Fu, Yizhen Yang, Zhenyun Hu, Zili Yang, Zhoutian Chen, Jinbin Wang, Juncheng Zhou, Zhongguo Xu, Li Chen, Minshan Zhang, Yaojun BMC Cancer Research BACKGROUND: Laparoscopic liver resection (LLR) is now widely performed in treating primary liver cancer (PLC) and yields equal long-term and superior short-term outcomes to those of open liver resection (OLR). The optimal surgical approach for resectable PLC (rPLC) remains controversial. Herein, we aimed to develop a nomogram to determine the most appropriate resection approach for the individual patient. METHODS: Patients with rPLC who underwent hepatectomy from January 2013 to December 2018 were reviewed. Prediction model for risky surgery during LLR was constructed. RESULTS: A total of 900 patients in the LLR cohort and 423 patients in the OLR cohort were included. A history of previous antitumor treatment, tumor diameter, tumor location and resection extent were independently associated with risky surgery of LLR. The nomogram which was constructed based on these risk factors demonstrated good accuracy in predicting risky surgery with a C index of 0.83 in the development cohort and of 0.76 in the validation cohort. Patients were stratified into high-, medium- or low-risk levels for receiving LLR if the calculated score was more than 0.8, between 0.2 and 0.8 or less than 0.2, respectively. High-risk patients who underwent LLR had more blood loss (441 ml to 417 ml) and a longer surgery time (183 min to 150 min) than those who received OLR. CONCLUSIONS: Patients classified into the high-risk level for LLR instead undergo OLR to reduce surgical risks and complications and patients classified into the low-risk level undergo LLR to maximize the advantages of minimally invasive surgery. TRIAL REGISTRATION: This study was registered in the Chinese Clinical Trial Registry (registration number: ChiCTR2100049446). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-023-10630-x. BioMed Central 2023-02-27 /pmc/articles/PMC9972775/ /pubmed/36849920 http://dx.doi.org/10.1186/s12885-023-10630-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Fu, Yizhen Yang, Zhenyun Hu, Zili Yang, Zhoutian Chen, Jinbin Wang, Juncheng Zhou, Zhongguo Xu, Li Chen, Minshan Zhang, Yaojun An integrated strategy for deciding open versus laparoscopic hepatectomy for resectable primary liver cancer |
title | An integrated strategy for deciding open versus laparoscopic hepatectomy for resectable primary liver cancer |
title_full | An integrated strategy for deciding open versus laparoscopic hepatectomy for resectable primary liver cancer |
title_fullStr | An integrated strategy for deciding open versus laparoscopic hepatectomy for resectable primary liver cancer |
title_full_unstemmed | An integrated strategy for deciding open versus laparoscopic hepatectomy for resectable primary liver cancer |
title_short | An integrated strategy for deciding open versus laparoscopic hepatectomy for resectable primary liver cancer |
title_sort | integrated strategy for deciding open versus laparoscopic hepatectomy for resectable primary liver cancer |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972775/ https://www.ncbi.nlm.nih.gov/pubmed/36849920 http://dx.doi.org/10.1186/s12885-023-10630-x |
work_keys_str_mv | AT fuyizhen anintegratedstrategyfordecidingopenversuslaparoscopichepatectomyforresectableprimarylivercancer AT yangzhenyun anintegratedstrategyfordecidingopenversuslaparoscopichepatectomyforresectableprimarylivercancer AT huzili anintegratedstrategyfordecidingopenversuslaparoscopichepatectomyforresectableprimarylivercancer AT yangzhoutian anintegratedstrategyfordecidingopenversuslaparoscopichepatectomyforresectableprimarylivercancer AT chenjinbin anintegratedstrategyfordecidingopenversuslaparoscopichepatectomyforresectableprimarylivercancer AT wangjuncheng anintegratedstrategyfordecidingopenversuslaparoscopichepatectomyforresectableprimarylivercancer AT zhouzhongguo anintegratedstrategyfordecidingopenversuslaparoscopichepatectomyforresectableprimarylivercancer AT xuli anintegratedstrategyfordecidingopenversuslaparoscopichepatectomyforresectableprimarylivercancer AT chenminshan anintegratedstrategyfordecidingopenversuslaparoscopichepatectomyforresectableprimarylivercancer AT zhangyaojun anintegratedstrategyfordecidingopenversuslaparoscopichepatectomyforresectableprimarylivercancer AT fuyizhen integratedstrategyfordecidingopenversuslaparoscopichepatectomyforresectableprimarylivercancer AT yangzhenyun integratedstrategyfordecidingopenversuslaparoscopichepatectomyforresectableprimarylivercancer AT huzili integratedstrategyfordecidingopenversuslaparoscopichepatectomyforresectableprimarylivercancer AT yangzhoutian integratedstrategyfordecidingopenversuslaparoscopichepatectomyforresectableprimarylivercancer AT chenjinbin integratedstrategyfordecidingopenversuslaparoscopichepatectomyforresectableprimarylivercancer AT wangjuncheng integratedstrategyfordecidingopenversuslaparoscopichepatectomyforresectableprimarylivercancer AT zhouzhongguo integratedstrategyfordecidingopenversuslaparoscopichepatectomyforresectableprimarylivercancer AT xuli integratedstrategyfordecidingopenversuslaparoscopichepatectomyforresectableprimarylivercancer AT chenminshan integratedstrategyfordecidingopenversuslaparoscopichepatectomyforresectableprimarylivercancer AT zhangyaojun integratedstrategyfordecidingopenversuslaparoscopichepatectomyforresectableprimarylivercancer |